Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study
M Badri, D Wilson, R Wood - The Lancet, 2002 - thelancet.com
Background Studies of the effect of highly active antiretroviral therapy (HAART) on the risk of
HIV-1-associated tuberculosis have had variable results. We set out to determine the effect …
HIV-1-associated tuberculosis have had variable results. We set out to determine the effect …
Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort
Objectives: To determine the long-term incidence of tuberculosis (TB) and associated risk
factors among individuals receiving HAART in South Africa. Design: Prospective cohort study. …
factors among individuals receiving HAART in South Africa. Design: Prospective cohort study. …
Adherence is not a barrier to successful antiretroviral therapy in South Africa
Objective: to determine adherence of an indigent African HIV-infected cohort initiating
antiretroviral therapy (ART); to identify predictors of incomplete adherence (< 95%) and virologic …
antiretroviral therapy (ART); to identify predictors of incomplete adherence (< 95%) and virologic …
[HTML][HTML] Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study
Background Data from Kwazulu Natal, South Africa, suggest that almost all patients with
extensively drug-resistant (XDR) tuberculosis are HIV-positive, with a fatal outcome. Since, there …
extensively drug-resistant (XDR) tuberculosis are HIV-positive, with a fatal outcome. Since, there …
Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study
…, B Mastrapa, X Padanilam, A Pooran, M Badri… - The Lancet, 2014 - thelancet.com
Background Long-term treatment-related outcomes in patients with extensively drug-resistant
(XDR) tuberculosis are unknown. We followed up a cohort of patients to address …
(XDR) tuberculosis are unknown. We followed up a cohort of patients to address …
Nursing homes as a reservoir of extended-spectrum β-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli
…, B Smyth, P Donaghy, M Badri… - Journal of …, 2009 - academic.oup.com
Background To assess the prevalence and risk factors for faecal carriage of fluoroquinolone-resistant,
extended-spectrum β-lactamase (ESBL)-producing, Escherichia coli (MDR E. coli) …
extended-spectrum β-lactamase (ESBL)-producing, Escherichia coli (MDR E. coli) …
CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment
Objectives: To determine the rate of CD4 decline and the incidence of opportunistic infections
(OIs) among antiretroviral therapy-naive South African HIV-infected patients and inform …
(OIs) among antiretroviral therapy-naive South African HIV-infected patients and inform …
T-cell interferon-γ release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings
K Dheda, R van Zyl Smit, M Badri… - Current opinion in …, 2009 - journals.lww.com
IGRAs may still be useful in high-burden settings in specific subgroups at high risk of
progression, including young children, HIV-infected individuals and healthcare workers, but this …
progression, including young children, HIV-infected individuals and healthcare workers, but this …
Within-subject variability and boosting of T-cell interferon-γ responses after tuberculin skin testing
…, R Meldau, J Kieck, J Juritz, M Badri… - American journal of …, 2009 - atsjournals.org
Rationale: The optimal strategy for the diagnosis of latent tuberculosis infection is controversial.
Adoption of a two-step strategy (tuberculin skin test [TST] followed by an IFN-γ release …
Adoption of a two-step strategy (tuberculin skin test [TST] followed by an IFN-γ release …
[HTML][HTML] Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples
Background The accurate diagnosis of TB in HIV-infected patients, particularly with advanced
immunosuppression, is difficult. Recent studies indicate that a lipoarabinomannan (LAM) …
immunosuppression, is difficult. Recent studies indicate that a lipoarabinomannan (LAM) …